BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Na DC, Lee JE, Yoo JE, Oh BK, Choi GH, Park YN. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study. Exp Mol Pathol. 2011;90:66-73. [PMID: 20969862 DOI: 10.1016/j.yexmp.2010.10.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Alfano D, Franco P, Stoppelli MP. Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View. Front Cell Dev Biol 2022;10:818616. [DOI: 10.3389/fcell.2022.818616] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Liu F, Qian Y. The role of CD133 in hepatocellular carcinoma. Cancer Biol Ther 2021;22:291-300. [PMID: 33899676 DOI: 10.1080/15384047.2021.1916381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kim H, Lee KW, Oh SC, Park MY, Seo S, Jin XL, Hong SK, Yoon KC, Yi NJ, Suh KS. Sirolimus and MMF are insufficient immunosuppressants for regulation of the proliferation of CD133+EpCAM+ cell populations in HCC cell lines. Biomed Rep 2020;13:69. [PMID: 33194193 DOI: 10.3892/br.2020.1376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sun NY, Yang MH. Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy. Front Oncol 2020;10:792. [PMID: 32509584 DOI: 10.3389/fonc.2020.00792] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
5 Marin JJG, Herraez E, Lozano E, Macias RIR, Briz O. Models for Understanding Resistance to Chemotherapy in Liver Cancer. Cancers (Basel) 2019;11:E1677. [PMID: 31671735 DOI: 10.3390/cancers11111677] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
6 Kang H, Kim H, Lee S, Youn H, Youn B. Role of Metabolic Reprogramming in Epithelial⁻Mesenchymal Transition (EMT). Int J Mol Sci 2019;20:E2042. [PMID: 31027222 DOI: 10.3390/ijms20082042] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 13.5] [Reference Citation Analysis]
7 Marin JJ, Briz O, Herraez E, Lozano E, Asensio M, Di Giacomo S, Romero MR, Osorio-padilla LM, Santos-llamas AI, Serrano MA, Armengol C, Efferth T, Macias RI. Molecular bases of the poor response of liver cancer to chemotherapy. Clinics and Research in Hepatology and Gastroenterology 2018;42:182-92. [DOI: 10.1016/j.clinre.2017.12.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 8.6] [Reference Citation Analysis]
8 Daniel SG, Russ AD, Guthridge KM, Raina AI, Estes PS, Parsons LM, Richardson HE, Schroeder JA, Zarnescu DC. miR-9a mediates the role of Lethal giant larvae as an epithelial growth inhibitor in Drosophila. Biol Open 2018;7:bio027391. [PMID: 29361610 DOI: 10.1242/bio.027391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Chen C, Yu G, Xiao W, Xing M, Ni J, Wan R, Hu G. Thalidomide inhibits proliferation and epithelial-mesenchymal transition by modulating CD133 expression in pancreatic cancer cells. Oncol Lett 2017;14:8206-12. [PMID: 29344263 DOI: 10.3892/ol.2017.7213] [Reference Citation Analysis]
10 Berretta M, Cavaliere C, Alessandrini L, Stanzione B, Facchini G, Balestreri L, Perin T, Canzonieri V. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget. 2017;8:14192-14220. [PMID: 28077782 DOI: 10.18632/oncotarget.13929] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
11 Xu JH, Chang WH, Fu HW, Shu WQ, Yuan T, Chen P. Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC. Biochem Biophys Res Commun. 2017;490:920-926. [PMID: 28651931 DOI: 10.1016/j.bbrc.2017.06.141] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
12 Zhang J, Zhang G, Hu P, Deng G, Liu Q, Qiao L, Luo H, Zhang J. Vasculogenic mimicry is associated with increased tumor-infiltrating neutrophil and poor outcome in esophageal squamous cell carcinoma. Onco Targets Ther 2017;10:2923-30. [PMID: 28652774 DOI: 10.2147/OTT.S135477] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
13 Zhang S, Zhang K, Ji P, Zheng X, Jin J, Feng M, Liu P. GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma. BMC Cancer 2017;17:380. [PMID: 28549418 DOI: 10.1186/s12885-017-3373-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
14 Wu SM, Lin SL, Lee KY, Chuang HC, Feng PH, Cheng WL, Liao CJ, Chi HC, Lin YH, Tsai CY. Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression. Int J Cancer. 2017;140:1581-1596. [PMID: 27925179 DOI: 10.1002/ijc.30559] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
15 Zimmermann A. Liver Cancer: Stem and Progenitor Cells. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2017. [DOI: 10.1007/978-3-319-26956-6_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Zimmermann A. Tumor Stroma, Desmoplasia, and Stromagenesis. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2017. [DOI: 10.1007/978-3-319-26956-6_185] [Reference Citation Analysis]
17 Liu Q, Qiao L, Liang N, Xie J, Zhang J, Deng G, Luo H, Zhang J. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions. J Cell Mol Med 2016;20:1761-9. [PMID: 27027258 DOI: 10.1111/jcmm.12851] [Cited by in Crossref: 50] [Cited by in F6Publishing: 63] [Article Influence: 7.1] [Reference Citation Analysis]
18 Zhang S, Li J, Liu P, Xu J, Zhao W, Xie C, Yin Z, Wang X. Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression. Oncotarget. 2015;6:11074-11086. [PMID: 25871475 DOI: 10.18632/oncotarget.3570] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
19 Zimmermann A. Tumor Stroma, Desmoplasia, and Stromagenesis. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2016. [DOI: 10.1007/978-3-319-26587-2_185-1] [Reference Citation Analysis]
20 Zimmermann A. Liver Cancer: Stem and Progenitor Cells. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2016. [DOI: 10.1007/978-3-319-26587-2_1-1] [Reference Citation Analysis]
21 Zhu Q, Ma C, Wang Q, Song Y, Lv T. The role of TWIST1 in epithelial-mesenchymal transition and cancers. Tumor Biol 2016;37:185-97. [DOI: 10.1007/s13277-015-4450-7] [Cited by in Crossref: 92] [Cited by in F6Publishing: 94] [Article Influence: 11.5] [Reference Citation Analysis]
22 Yu J, Sun W, Hua F, Xie J, Lin H, Zhou D, Hu Z. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells. Cancer Letters 2015;365:190-200. [DOI: 10.1016/j.canlet.2015.05.029] [Cited by in Crossref: 54] [Cited by in F6Publishing: 65] [Article Influence: 6.8] [Reference Citation Analysis]
23 Ha NH, Woo BH, Kim DJ, Ha ES, Choi JI, Kim SJ, Park BS, Lee JH, Park HR. Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties. Tumour Biol. 2015;36:9947-9960. [PMID: 26178482 DOI: 10.1007/s13277-015-3764-9] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 8.4] [Reference Citation Analysis]
24 Zou H, Feng X, Cao J. Twist in hepatocellular carcinoma: pathophysiology and therapeutics. Hepatol Int 2015;9:399-405. [DOI: 10.1007/s12072-015-9634-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
25 Huang W, Gao F, Li K, Wang W, Lai YR, Tang SH, Yang DH. Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma. World J Gastroenterol 2015; 21(10): 3055-3065 [PMID: 25780306 DOI: 10.3748/wjg.v21.i10.3055] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Sha L, Dong L, Lv L, Bai L, Ji X. HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-β1 pathway in hepatocellular carcinoma cells. Clin Exp Med 2015;15:55-64. [PMID: 25081022 DOI: 10.1007/s10238-014-0276-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
27 Panebianco C, Saracino C, Pazienza V. Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression. Tumour Biol 2014;35:7307-15. [PMID: 24833096 DOI: 10.1007/s13277-014-2075-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
28 Wang F, Dai W, Wang Y, Shen M, Chen K, Cheng P, Zhang Y, Wang C, Li J, Zheng Y, Lu J, Yang J, Zhu R, Zhang H, Zhou Y, Xu L, Guo C. The synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinoma. PLoS One 2014;9:e97414. [PMID: 24816638 DOI: 10.1371/journal.pone.0097414] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
29 Ding Q, Miyazaki Y, Tsukasa K, Matsubara S, Yoshimitsu M, Takao S. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis. Mol Cancer. 2014;13:15. [PMID: 24468059 DOI: 10.1186/1476-4598-13-15] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 5.8] [Reference Citation Analysis]
30 Svinka J, Mikulits W, Eferl R. STAT3 in hepatocellular carcinoma: new perspectives. Hepatic Oncol. 2013;1:107-120. [PMID: 30190945 DOI: 10.2217/hep.13.7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
31 Bose SK, Meyer K, Di Bisceglie AM, Ray RB, Ray R. Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes. J Virol. 2012;86:13621-13628. [PMID: 23035229 DOI: 10.1128/jvi.02016-12] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
32 DI Fazio P, Montalbano R, Quint K, Alinger B, Kemmerling R, Kiesslich T, Ocker M, Neureiter D. The pan-deacetylase inhibitor panobinostat modulates the expression of epithelial-mesenchymal transition markers in hepatocellular carcinoma models. Oncol Lett 2013;5:127-34. [PMID: 23255907 DOI: 10.3892/ol.2012.951] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
33 Chen D, Wang Y, Zhang K, Jiao X, Yan B, Liang J. Antisense oligonucleotide against clusterin regulates human hepatocellular carcinoma invasion through transcriptional regulation of matrix metalloproteinase-2 and E-cadherin. Int J Mol Sci 2012;13:10594-607. [PMID: 22949882 DOI: 10.3390/ijms130810594] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
34 Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ, Wang H, Wang Y, Li R, Yang Y, Zhao X. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. BMC Med. 2012;10:85. [PMID: 22871210 DOI: 10.1186/1741-7015-10-85] [Cited by in Crossref: 102] [Cited by in F6Publishing: 116] [Article Influence: 9.3] [Reference Citation Analysis]
35 Fang L, Zhang HB, Li H, Fu Y, Yang GS. miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90(+) HepG2 cells. Radiol Oncol. 2012;46:233-241. [PMID: 23077462 DOI: 10.2478/v10019-012-0025-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
36 Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee JE, Cho JY, Yoo JE, Choi JS, Park YN. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis. Hepatology 2011;54:1707-17. [PMID: 22045674 DOI: 10.1002/hep.24559] [Cited by in Crossref: 247] [Cited by in F6Publishing: 250] [Article Influence: 20.6] [Reference Citation Analysis]
37 Yao XH, Ping YF, Bian XW. Contribution of cancer stem cells to tumor vasculogenic mimicry. Protein Cell. 2011;2:266-272. [PMID: 21533771 DOI: 10.1007/s13238-011-1041-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]